Treatment of bulimia with antidepressants: theoretical considerations and clinical findings.
D000293:Adolescent; D000328:Adult; D000856:Anorexia Nervosa / Q000235:genetics; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000235:genetics; D003907:Dexamethasone; D004311:Double-Blind Method; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006963:Hyperphagia / Q000188:drug therapy* / Q000235:genetics / Q000523:psychology; D007099:Imipramine / Q000627:therapeutic use; D008950:MMPI; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D013973:Thyrotropin-Releasing Hormone; D003907:Dexamethasone; D013972:Thyrotropin; D007099:Imipramine; D006854:Hydrocortisone